$30.1 Million
Otonomy, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$129.0 Million
Savara Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$64.6 Million
Jounce Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$56.5 Million
Marker Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$69.4 Million
Kaleido Biosciences
Confidentially Marketed Follow-On Offering
Active Bookrunner
$86.3 Million
Neuronetics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$75.6 Million
Syros Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$50.6 Million
Fulcrum Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$52.8 Million
Catalyst Biosciences, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$73.8 Million
MeiraGTx Holdings plc
Confidentially Marketed Follow-On Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2024 Piper Sandler Companies. Since 1895. All rights reserved.